ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

National Poll: Voters Overwhelmingly Favor Strong PBM Reform

Alexandria, Va., April 27, 2023 (GLOBE NEWSWIRE) -- As Congress readies legislation aimed at drug prices and marketplace fairness, a new national poll released today by the National Community Pharmacists Association shows strong bipartisan support for regulating the shadowy corporate middlemen who control almost everyone’s prescriptions. 

“When you explain to voters the dominant role that PBMs play in the prescription drug market, and the outsized control they have over patients and their health care providers, they are very concerned. The data makes that crystal clear, and it cuts across every political and demographic group. If ever there was an opportunity for Congress to pass bipartisan reform, that time is right now,” said NCPA CEO B. Douglas Hoey, pharmacist, MBA. 

According to the poll, taken by Morning Consult, voters know very little or nothing at all about pharmacy benefit managers, the largest three of which control 80 percent of all prescriptions in the U.S. Eighty percent are concerned that PBMs steer patients to pharmacies they own or control to maximize their own profit. Seventy-eight percent are concerned that PBMs often require patients to use their own mail-order pharmacies instead of local pharmacies. And 80 percent are concerned that PBMs keep all or most of the discounts on drugs they negotiate instead of passing the savings on to consumers.

“The numbers are staggering. Large majorities of Republicans, Democrats, and Independents are concerned by the PBMs’ self-serving and anti-competitive practices. That’s consistent across racial groups, gender groups, and age groups. PBMs have operated for decades with very little oversight, and voters in every state and congressional district know instinctively that meaningful reform is necessary,” said Hoey. 

The poll, conducted between April 19 and April 22, sampled 1,969 registered voters. Seventy-six percent are concerned that PBMs reimburse local pharmacies less for medicines than it costs the pharmacies to purchase and dispense them. Voters don’t like that PBMs overcharge employer and taxpayer-funded programs for drugs and pocket the difference. And 80 percent are concerned that just three PBMs control 80 percent of the prescription drug market. Moreover, large majorities of voters support specific reforms that Congress can pass now.

For example, 76 percent of voters would support a ban on patient steering. Seventy-five percent say Congress should ban PBMs from penalizing patients who use their own pharmacies instead of those owned or controlled by PBMs. Three-quarters believe Congress should require PBMs and insurance companies to reimburse local pharmacies at least what it costs them to purchase and dispense drugs. And when PBMs negotiate rebates on drugs to include in their insurance plans, they should be required to pass the savings on to patients, say 78 percent of voters. 

“Basically, voters are concerned by the entire PBM business model. Almost all their practices meet with widespread public disapproval. The political ground is very fertile for meaningful reform that treats taxpayer dollars responsibly and pays pharmacies fairly,” said Hoey. 

In fact, the poll shows overwhelming support for more aggressive reforms over narrower options. For example, voters were asked to consider two plans: the first would ban patient steering; ban PBMs from excluding cheaper generic drugs in favor of more expensive brand-names; require PBMs to share rebates with patients; and require broad transparency in PBM practices. The second plan would ban spread pricing; force PBMs to share discounts with health insurance companies instead of patients; and tell government agencies how much they’re getting in discounts from drug manufacturers. Seventy-five percent of voters chose the first plan, a strong signal that Congress should focus on comprehensive reform that benefits patients directly. 

In another question, the identical majority – 75 percent – favor a rule forcing PBMs to report key financial information with government regulators over a rule requiring them to simply share certain information with health insurance companies and employers. 

“Voters want real transparency, public accountability, and a non-coerced choice as to where they get their prescriptions,” said Hoey. “Both of those are necessary for a healthy market that can produce more choices and lower prices for patients and taxpayers.” 

To see the entire poll, click here.

###

Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing over 19,400 pharmacies that employ nearly 240,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit www.ncpa.org.

Attachments


Andie Pivarunas
National Community Pharmacists Association
703-600-1174
andrea.pivarunas@ncpa.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.